Prevención y manejo de la hipertrofia ventricular izquierda en pacientes adultos obesos

Abstract

In Ecuador, cardiovascular risks are the leading cause of death, among them we have Left Ventricular Hypertrophy and the risk factors are arterial hypertension, but current studies have characterized that obesity independently can also trigger this pathology, affecting more women than men. and thus, promotes primary prevention and early diagnosis. It was evidenced that overweight and obesity in childhood are associated with cardiovascular damage, however, this significantly increased morbidity and mortality in adulthood, leading to advanced LVH. Antihypertensives arrest the progress and improve left ventricular hypertrophy, as well as weight loss or dietary sodium restriction have additional beneficial effects on the cardiovascular system. A significant benefit has also been shown in therapeutic management such as thiazide diuretics, renin-angiotensin-aldosterone system (RAAS) inhibitors and calcium channel blockers (CCBs) up to sodium-glucose cotransporter type 2 inhibitors. (SGLT2).